Mensia Technologies SA

Medical Devices

  • Headquarters: Plateforme d'incubation Boucicaut, 130 rue de Lourmel, Paris, France, 75015

Phone: NA

Founded: 2012

Employees: 0-10

Stock Exchange: NA

About Mensia Technologies SA

Based in Rennes and Paris (France), Mensia Technologies is a revenue-generating medical device company developing ground-breakin ... g, home-care medical solutions for the care of the Central Nervous System (CNS). Our first product is a fully automated personalized neurofeedback training (NFT) system for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). We are currently testing it in the largest randomized clinical trial of its kind in 5 European countries. This medical device, Mensia Koala, once clinically validated, will provide an alternative to symptomatic psychoactive medication like methylphenidate (MPH) and will be made available to patients through prescription. On a 5-year horizon, and beyond ADHD, we intend to leverage our proprietary, real-time brain signal processing, and know-how in neurosciences to develop or co-develop additional game-changing medical devices in pathologies such as chronic pain, the cognitive impairment of seniors or motor function rehabilitation. Show more

Join Ampliz To Reach Decision Makers At Mensia Technologies SA

Reach Decision Makers At
Mensia Technologies SA

Book a Demo

Frequently Asked Questions Regarding Mensia Technologies SA

Where are Mensia Technologies SA’s headquarters?

Mensia Technologies SA’s headquarters are in Plateforme d'incubation Boucicaut, 130 rue de Lourmel, Paris, France, 75015

What is Mensia Technologies SA’s industry?

Mensia Technologies SA is in the industry of: Medical Devices

What is Mensia Technologies SA’s official website?

Mensia Technologies SA’s official website is www.mensiatech.com

How many employees are working in Mensia Technologies SA?

Mensia Technologies SA has 0-10 employees

Company_logo Company Directory Search
Company_logo
Reach your target accounts faster with Ampliz
logo © Copyright 2023 Ampliz Pvt. Ltd.